SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-15-089213
Filing Date
2015-03-12
Accepted
2015-03-12 16:06:06
Documents
1
Group Members
BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND V, L.P.BAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D d887577dsc13da.htm SC 13D/A 75688
  Complete submission text file 0001193125-15-089213.txt   77458
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Subject) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86934 | Film No.: 15695953
SIC: 2834 Pharmaceutical Preparations